Compare BridgeBio Pharma Inc (BBIO) vs Intuitive Surgical, Inc. (ISRG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BridgeBio Pharma Inc vs Intuitive Surgical, Inc. — how do they compare? BridgeBio Pharma Inc trades at $83.9 (market cap $16.36B), while Intuitive Surgical, Inc. trades at $405.5 (market cap $141.75B). The key difference: Intuitive Surgical, Inc. is far larger — about 8.7× BridgeBio Pharma Inc's market cap, and BridgeBio Pharma Inc is trading nearer its 52-week high, Intuitive Surgical, Inc. nearer its low. Which is the better fit depends on your goals.
| BBIO | ISRG | |
|---|---|---|
Market Cap | $16.36B | $141.75B |
Sector | Health | Health |
52-Week High | $90.17 | $592.85 |
52-Week Low | $47.29 | $332.02 |
Enterprise Value | $18.14B | $136.53B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BridgeBio Pharma Inc
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.
Read more on BBIO →About Intuitive Surgical, Inc.
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 7,000 da Vinci systems in hospitals worldwide, with more than 4,000 installations in the United States and a growing number in emerging markets.
Read more on ISRG →
